Analysts think SLS stock price could increase by 398%
Aug 02, 2024, 6:25 AM
4.47%
What does SLS do
SELLAS Life Sciences Group, Inc., a clinical-stage biopharmaceutical company based in New York City, focuses on developing immunotherapeutics like galinpepimut-S and GFH009 for various cancer types. Founded in 2008, the company employs 17 people and targets cancer with treatments licensed from institutions like Memorial Sloan Kettering Cancer Center and GenFleet Therapeutics.
4 analysts think SLS stock price will increase by 397.56%. The current median analyst target is $6.12 compared to a current stock price of $1.23. The lowest analysts target is $4.04 and the highest analyst target is $7.88.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.